Key Points
-
The crystalline form of a drug affects properties such as its solubility, stability, dissolution rate, bioavailability and tabletability, and so understanding the crystalline state is crucial for many of the activities of the pharmaceutical industry.
-
This article first discusses the fundamental concepts of the crystalline state, focusing on those relevant to the properties of pharmaceutical crystals.
-
Methods for determination of the crystal structure of pharmaceutical crystals are then described. In particular, recent advances in the use of computational approaches in crystal structure solution and prediction are highlighted.
-
Finally, the potential of crystal engineering to design novel pharmaceutical compounds with desired physical and mechanical properties is reviewed.
Abstract
Most marketed pharmaceuticals consist of molecular crystals. The arrangement of the molecules in a crystal determines its physical properties and, in certain cases, its chemical properties, and so greatly influences the processing and formulation of solid pharmaceuticals, as well as key drug properties such as dissolution rate and stability. A thorough understanding of the relationships between physical structures and the properties of pharmaceutical solids is therefore important in selecting the most suitable form of an active pharmaceutical ingredient for development into a drug product. In this article, we review the different crystal forms of pharmaceuticals, the challenges that they present and recent advances in crystal structure determination. We then discuss computational approaches for predicting crystal properties. Finally, we review the analysis of crystal structures in furthering crystal engineering to design novel pharmaceutical compounds with desired physical and mechanical properties.
Similar content being viewed by others
References
Vippagunta, S. R., Brittain, H. G. & Grant, D. J. W. Crystalline solids. Adv. Drug Deliv. Rev. 48, 3–26 (2001). Review of the structure and properties of crystalline pharmaceuticals.
Byrn, S. R., Pfeiffer, R. R. & Stowell, J. G. Solid State Chemistry of Drugs (SSCI, West Lafayette, 1999).
Hancock, B. C. & Zografi, G. Characteristics and significance of the amorphous state in pharmaceutical systems. J. Pharm. Sci. 86, 1–12 (1997).
Borka, L. & Haleblian, J. K. Crystal polymorphism of pharmaceuticals. Acta Pharm. Jugosl. 40, 71–94 (1990).
Haleblian, J. K. Characterization of habits and crystalline modification of solids and their pharmaceutical applications. J. Pharm. Sci. 64, 1269–1288 (1975).
Brittain, H. G. & Fiese, E. F. in Polymorphism in Pharmaceutical Solids (ed. Brittain, H. G.) 331–362 (Marcel Dekker, New York, 1999).
Phadnis, N. V. & Suryanarayanan, R. Polymorphism in anhydrous theophylline: implications on the dissolution rate of theophylline tablets. J. Pharm. Sci. 86, 1256–1263 (1997).
Otsuka, M. & Matsuda, Y. Effects of environmental temperature and compression energy on polymorphic transformation during tableting. Drug Dev. Ind. Pharm. 19, 2241–2269 (1993).
Otsuka, M., Hasegawa, H. & Matsuda, Y. Effect of polymorphic transformation during the extrusion-granulation process on the pharmaceutical properties of carbamazepine granules. Chem. Pharm. Bull. 45, 894–898 (1997).
Otsuka, M., Hasegawa, H. & Matsuda, Y. Effect of polymorphic forms of bulk powders on pharmaceutical properties of carbamazepine granules. Chem. Pharm. Bull. 47, 852–856 (1999).
Otsuka, M., Nakanishi, M. & Matsuda, Y. Effects of crystalline form on the tableting compression mechanism of phenobarbital polymorphs. Drug Dev. Ind. Pharm. 25, 205–215 (1999).
Otsuka, M., Ohtani, H., Otsuka, K. & Kaneniwa, N. Effect of humidity on solid-state isomerization of various kinds of lactose during grinding. J. Pharm. Pharmacol. 45, 2–5 (1993).
Wong, M. W. Y. & Mitchell, A. G. Physicochemical characterization of a phase change produced during the wet granulation of chlorpromazine hydrochloride and its effects on tableting. Int. J. Pharm. 88, 261–273 (1992).
Miyamae, A. et al. X-ray powder diffraction study on the grinding effect of the polymorphs of a novel and orally effective uricosuric agent: FR76505. Drug Dev. Ind. Pharm. 20, 2881–2897 (1994).
Chongprasert, S. et al. Effects of freeze-dry processing conditions on the crystallization of pentamidine isethionate. J. Pharm. Sci. 87, 1155–1160 (1998).
Morris, K. R., Griesser, U. J., Eckhardt, C. J. & Stowell, J. G. Theoretical approaches to physical transformations of active pharmaceutical ingredients during manufacturing processes. Adv. Drug Deliv. Rev. 48, 91–114 (2001). Explains the importance of crystal structure in pharmaceutical processing.
Morris, K. R. et al. Advances in pharmaceutical materials and processing. Pharm. Sci. Technol. Today 1, 235–245 (1998).
Khankari, R. K. & Grant, D. J. W. Pharmaceutical hydrates. Thermochim. Acta 248, 61–79 (1995).
Grant, D. J. W. in Polymorphism in Pharmaceutical Solids (ed. Brittain, H. G.) 1–33 (Marcel Dekker, New York, 1999).
Ghosh, S., Ojala, W. H., Gleason, W. B. & Grant, D. J. W. Relationships between crystal structures, thermal properties and solvate stability of dialkylhydroxypyridones and their formic acid solvates. J. Pharm. Sci. 84, 1392–1399 (1995).
Ojala, W. H., Khankari, R. K., Grant, D. J. W. & Gleason, W. B. Crystal structures and physical chemical properties of nedocromil zinc heptahydrate and nedocromil magnesium pentahydrate. J. Chem. Crystallog. 26, 167–178 (1996).
Giordiano, F. et al. Physical properties of parabens and their mixtures: solubility in water, thermal behavior, and crystal structures. J. Pharm. Sci. 88, 1210–1216 (1999).
Zhu, H. J., Young, V. G. Jr & Grant, D. J. W. Crystal structure and thermal behavior of nedocromil nickel octahydrate. Int. J. Pharm. 232, 23–33 (2002).
Brittain, H. G. The impact of polymorphism on drug development: a regulatory viewpoint. Am. Pharm. Rev. 3, 67–68, 70 (2000). Explains the regulatory issues related to the polymorphism of pharmaceuticals.
Bernstein, J. Polymorphism in Molecular Crystals (Oxford Univ. Press, New York, 2002). Comprehensively summarizes the current knowledge and understanding of the polymorphism of molecular crystals.
Morris, K. R. in Polymorphism in Pharmaceutical Solids (ed. Brittain, H. G.) 125–181 (Marcel Dekker, New York, 1999).
Andreetti, G. D. Crystallographic studies of inclusion compounds. Inclusion Compounds 3, 129–146 (1984).
Lipkowski, J. in Crystallography of Supramolecular Compounds NATO Science Series C Vol. 480 (eds Tsoucaris, G. et al.) 265–283 (Kluwer Academic, Boston, 1996).
Brittain, H. G. & Grant D. J. W. in Polymorphism in Pharmaceutical Solids (ed. Brittain, H. G.) 279–330 (Marcel Dekker, New York, 1999).
Bechtloff, B., Nordhoff, S. & Ulrich, J. Pseudopolymorphs in industrial use. Cryst. Res. Technol. 36, 1315–1328 (2001). Explains the importance of pseudopolymorphs (solvates and hydrates) in the pharmaceutical industry.
Berge, S. M., Bighley, L. D. & Monkhouse, D. C. Pharmaceutical salts. J. Pharm. Sci. 66, 1–19 (1977).
Neau, S. H. in Water-Insoluble Drug Formations (ed. Liu, R.) 405–425 (Interpharm, Buffalo Grove, 2000).
Puddipeddi, M., Serajuddin, A. T. M., Grant, D. J. W. & Stahl, P. H. in Handbook of Pharmaceutical Salts: Properties, Selection, and Use (eds Stahl, P. H. & Wermuth, C. G.) 19–38 (Wiley, Weinheim, 2002).
Giron, D. & Grant, D. J. W. in Handbook of Pharmaceutical Salts: Properties, Selection, and Use (eds Stahl, P. H. & Wermuth, C. G.) 41–81 (Wiley, Weinheim, 2002). Explains the importance of salt forms of pharmaceuticals in the stabilization and processing of pharmaceutical formulations.
Stahl, P. H. & Byrn, S. R. in Molecular Modeling Applications in Crystallization (ed. Myerson, A. S.) 313–345 (Cambridge Univ. Press, New York, 1999).
Shah, R. D. & Nafie, L. A. Spectroscopic methods for determining enantiomeric purity and absolute configuration in chiral pharmaceutical molecules. Curr. Opin. Drug Discov. Devel. 4, 764–775 (2001).
van Eikeren, P. Commercial manufacture of chiral pharmaceuticals. Chiral Separations 9–35 (1997).
Gu, C. H. & Grant, D. J. W. in Handbook of Experimental Pharmacology: Stereochemical Aspects of Drug Action and Disposition Vol. 153 (eds Eichelbaum M., Testa, B. & Somogyi, A.) 113–137 (Springer, Berlin, 2003). Explains the structural basis of the solid-state properties of chiral pharmaceuticals.
Li, Z. J. & Grant, D. J. W. Relationship between physical properties and crystal structures of chiral drugs. J. Pharm. Sci. 86, 1073–1078 (1997).
Abgada, C. O. & York, P. Dehydration of theophylline monohydrate powder: effects of particle size and sample weight. Int. J. Pharm. 106, 33–40 (1994).
Sun, C. & Grant, D. J. W. Improved tableting properties of p-hydroxybenzoic acid by water of crystallization — a molecular insight. Pharm. Res. (in the press).
Bandopadhyay, R. & Grant, D. J. W. Plasticity and slip system of plate-shaped crystals of L-lysine monohydrochloride dihydrate. Pharm. Res. 19, 491–496 (2002).
Sun, C. & Grant, D. J. W. Influence of crystal structure on the tableting properties of sulfamerazine polymorphs. Pharm. Res., 18, 274–280 (2001).
Cullity, B. D. Elements of X-ray Diffraction 3rd edn (Prentice Hall, New Jersey, 2001). Provides an excellent introduction to crystal structures and X-ray crystallography.
Buerger, M. J. Elementary Crystallography 253–273 (Wiley Interscience, New York, 1963).
Zorky, P. M. Symmetry, pseudosymmetry and hypersymmetry of organic crystals. J. Mol. Struct. 374, 9–28 (1996).
Cambridge Crystallographic Data Centre, Cambridge Structural Database, University Chemical Laboratory, Cambridge, UK (1999). This databank includes more than 250,000 crystal structures and is a site reference for crystal structure reports.
Perlstein, J. in Crystal Engineering: from Molecules and Crystals to Materials NATO Science Series C Vol. 538 (eds Braga, D., Grepini, F. & Orpen, G. A.) 23–42 (Kluwer Academic, Boston, 1999).
Buckingham, A. D. in Crystal Engineering: the Design and Application of Functional Solids NATO Science Series C Vol. 539 (eds Seddon, K. R. & Zaworotko, M.) 49–68 (Kluwer Academic, Boston, 1999).
Pimental, G. C. & McClennan, A. L. The Hydrogen Bond (W. H. Freeman, San Francisco, 1960).
Scheiner, S. Hydrogen Bonding: A Theoretical Perspective (Oxford Univ. Press, Oxford, 1997).
Desiraju, G. R. Hydrogen bridges in crystal engineering: interactions without borders. Acc. Chem. Res. 35, 565–573 (2002).
Jeffrey, G. A. An Introduction to Hydrogen Bonding (Oxford Univ. Press, New York, 1997).
Desiraju, G. R. & Steiner, T. The Weak Hydrogen Bond in Structural Chemistry and Biology (IUCr Monographs on Crystallography 9) 15–47 (Oxford Univ. Press, New York, 1999).
Beyer, A., Karpfen, A. & Schuster, P. Energy surfaces of hydrogen complexes in the vapour phase. Topics Curr. Chem. 120, 1–40 (1984).
Perlstein, J. Molecular self-assemblies 4. Using Kitaigorodskii's Aufbau principle for quantitatively predicting the packing geometry of semiflexible organic molecules in translation monolayer aggregates. J. Am. Chem. Soc. 116, 11420–11432 (1994).
Smith, E. R. Electrostatic energy in ionic crystals. Proc. R. Soc. Lond. A 375, 475–505 (1981).
Haleblian, J. K. & McCrone, W. C. Pharmaceutical applications of polymorphism. J. Pharm. Sci. 58, 911–929 (1969).
Burger, A. & Ramberger, R. On the polymorphism of pharmaceuticals and other molecular crystals. I. Theory of thermodynamic rules. Mikrochim. Acta II, 259–271 (1979).
Burger, A. & Ramberger, R. On the polymorphism of pharmaceuticals and other molecular crystals. II. Applicability of thermodynamic rules. Mikrochim. Acta II, 273–316 (1979).
Henck, J. O. & Kuhnert-Brandstatter, M. Demonstration of the terms enantiotropy and monotropy in polymorphism research exemplified by flurbiprofen. J. Pharm. Sci. 88, 103–108 (1999).
Yu, L., Reutzel, S. M. & Stephenson, G. A. Physical characterization of polymorphic drugs: an integrated characterization strategy. Pharm. Sci. Technol. Today 1, 118–127 (1998).
Grunenberg, A., Henck, J. O. & Siesler, H. W. Theoretical derivation and practical application of energy/temperature diagrams as an instrument in preformulation studies of polymorphic drug substances. Int. J. Pharm. 129, 147–158 (1996).
Yu, L. Inferring thermodynamic stability relationship of polymorphs from melting data. J. Pharm. Sci. 84, 966–974 (1995).
Gu, C. H., Young, V. Jr & Grant, D. J. W. Polymorph screening: influence of solvents on the rate of solvent-mediated polymorphic transformation. J. Pharm. Sci. 90, 1878–1890 (2001).
Toscani, S. An up-to-date approach to drug polymorphism. Thermochim. Acta 321, 73–79 (1998).
Stahl, P. H. in Towards Better Safety of Drugs and Pharmaceutical Products (ed. Braimer, D. D.) 265–280 (Elsevier/North-Holland Biomedical, Amsterdam, 1980).
Giron, D. et al. Solid state characterizations of pharmaceutical hydrates. J. Thermal Anal. Cal. 68, 453–465 (2002).
Morris, K. & Rodriguez-Hornedo, N. in Encyclopaedia of Pharmaceutical Technology Vol. 7 (eds Swarbrick, J. & Boylan, J. C.) 393–440 (Marcel Dekker, New York, 1993).
Florey, K. in Analytical Profiles of Drug Substances Vol. 2 (ed. Florey, K.) 1–62 (Academic, New York, 1973).
Sugawara, Y., Kamiya, N., Iwasaki, H., Ito, T. & Satow, Y. Humidity controlled reversible structure transition of disodium adenosine 5'-triphosphate between dihydrate and trihydrate in a single crystal state. J. Am. Chem. Soc. 113, 5440–5445 (1991).
Sun, C., Zhou, D., Grant, D. J. W. & Young, V. G. Jr. Theophylline monohydrate. Acta Cryst. E 58, O368–O370 (2002).
Cox, J. S. G., Woodgard, G. D. & McCrone, W. C. Solid state chemistry of cromolyn sodium (disodium cromoglycate). J. Pharm. Sci. 60, 1458–1465 (1971).
Stephenson, G. A. & Diseroad, B. A. Structural relationship and desolvation behaviour of cromolyn cefazolin and fenoprofen sodium hydrates. Int. J. Pharm. 198, 167–177 (2000).
Chen, L. R., Young, V. G., Lechuga-Ballesteros, D. & Grant, D. J. W. Solid state behavior of cromolyn sodium hydrates. J. Pharm. Sci. 88, 1191–1200 (1999).
Zhu, J., Padden, B. E., Munson, E. J. & Grant, D. J. W. Physicochemical characterization of nedocromil bivalent metal salt hydrates. 2. Nedocromil zinc. J. Pharm. Sci. 86, 418–428 (1997).
Khankari, R. K., Ojala, W. H., Gleason, W. B. & Grant, D. J. W. Crystal structure of nedocromil sodium heptahemihydrate and its comparison with that of nedocromil sodium trihydrate. J. Chem. Crystallogr. 25, 859–866 (1995).
Ahlqvist, M. U. A. & Taylor, L. S. Water dynamics in channel hydrates investigated using H/D exchange. Int. J. Pharm. 241, 253–261 (2002).
Li, Z. J. & Grant, D. J. W. Relationship between physical properties and crystal structures of chiral drugs. J. Pharm. Sci. 86, 1073–1078 (1997).
Reddy, I. K., Kommuru, T. R., Zaghloul, A. A. & Khan, M. A. Chirality and its implications in transdermal drug development. Crit. Rev. Ther. Drug Carrier Syst. 17, 285–325 (2000).
Collet, A. & Vigne-Maeder, F. Increase of the occurrence of spontaneous resolution due to the crystallization of racemates under high pressure. New J. Chem. 19, 877–880 (1995).
Jacques, J., Collet, A. & Wilen, S. H. Enantiomers, Racemates, and Resolutions 3–213 (John Wiley & Sons, New York, 1981).
Burger, A., Rollinger, J. M. & Brueggeller, P. Binary system of (R)- and (S)-nitrendipine-polymorphism and structure. J. Pharm. Sci. 86, 674–679 (1997).
Kuhnert-Brandstaetter, M. & Ulmer, R. Contribution to the thermal analysis of optical antipodes-mandelic acid. Mikrochim. Acta 5, 927–935 (1974).
Langhammer, L. Binary systems of enantiomeric nicotine derivatives. Arch. Pharm. 308, 933–939 (1975).
Zhang, G. G. Z., Paspal, S. Y. L., Suryanarayanan, R. & Grant, D. J. W. Racemic species of sodium ibuprofen: characterization and polymorphic relationships. J. Pharm. Sci. 92, 1356–1366 (2003).
Jacques, J. & Gabard, J. Optical antipode mixtures. III. Solubility diagrams for several types of racemates. Bull. Soc. Chim. Fr. 1, 342–350 (1972).
Flack, H. D. Chiral and achiral crystal structure. Helv. Chim. Acta 86, 907–921 (2003).
Bel'skii, V. K. & Zorkii, P. M. Distribution of organic homomolecular crystals by chiral types and structural classes. Acta Cryst. A33, 1004–1006 (1977).
Stout, G. H. & Jensen, L. H. X-Ray Structure Determination: A Practical Guide 2nd edn (John Wiley & Sons, New York, 1989).
Fagan, P. G., Hammond, R. B., Roberts, K. J., Docherty, R. & Edmondson, M. in Crystal Growth of Organic Materials Third International Workshop on Crystal Growth of Organic Materials Conference (eds Myerson, A., Green, D.A. & Meenan, P.) 22–27 (Oxford Univ. Press, New York, 1996).
Jones, P. G. Crystal growing. Chem. Br. 17, 222–225 (1981). Describes the common methods for growing single crystals.
Threlfall, T. L. Analysis of organic polymorphs, a review. Analyst 120, 2435–2460 (1995).
Guillory, J. K. in Polymorphism in Pharmaceutical Solids (ed. Brittain, H. G.) 183–226 (Marcel Dekker, New York, 1999).
Mullin, J. W. Crystallization 4th edn (Butterworth–Heinemann, Boston, 2001).
Mitchell, C. A., Yu, L. & Ward, M. D. Selective nucleation and discovery of organic polymorphs through epitaxy with single crystal substrate. J. Am. Chem. Soc. 123, 10830–10839 (2001).
Hilden, J. L. et al. Capillary precipitation of a highly polymorphic organic compound. Cryst. Growth Des. 3, 921–926 (2003).
Zaccaro, J., Matic, J., Myerson, A. S. & Garetz, B. A. Nonphotochemical, laser-induced nucleation of supersaturated aqueous glycine produces unexpected γ-polymorph. Cryst. Growth Des. 1, 5–8 (2001). References 96–98 describe newer methods of generating polymorphs: epitaxy, capillary crystallization and laser-induced nucleation.
Beckmann, W., Otto, W. & Budde, U. Crystallization of the stable polymorph of hydroxytriendione: seeding process and effects of purity. Org. Process Res. Dev. 5, 387–392 (2001).
Wang, B., Lu, Z. P., Shi, E. W. & Zhong, W. Z. Twinning morphologies and mechanisms of β-BaB2O4 (BBO) crystal grown by TSSG method. Cryst. Res. Technol. 33, 929–935 (1998).
Wadhawan, V. K. A tensor classification of twinning in crystals. Acta Cryst. A 53, 546–555 (1997).
von Laue, M. Eine quantitative prüfung der theorie für die interferenz-erscheinungen bei röntgenstrahlen. Sitz. Math. Phys. Klasse Bayer. Akad. Wiss. 363–373 (1912).
Bragg, W. L. Diffraction of short electromagnetic waves by a crystal. Proc. Cambridge Philos. Soc. 17, 43–57 (1913).
Giacovazzo, C. Fundamentals of Crystallography (Oxford Univ. Press, New York, 2002).
Hanh, T. International Table of Crystallography Vol. A 5th edn (Kluwer Academic, Dordrecht, 2002).
Sayre, D. in Computational Crystallography (ed. Sayre, D.) 65–140 (Claredon, Oxford, 1982).
Giacovazzo, C. in International Tables for Crystallography 2nd edn Vol. B (ed. Shmueli, U.) 210–234 (Kluwer Academic, Dordrecht, 2002).
Giacovazzo, C. Direct Phasing in Crystallography: Fundamentals and Applications (Oxford Univ. Press, Oxford, 1998). Explains the most common technique for solving crystal structures from single crystal X-ray diffraction patterns.
Kirkpatrick, S., Gelatt, C. D. & Vecchi, M. P. Optimization by simulated annealing. Science 220, 671–680 (1983). This seminal paper explains the value and the process of simulated annealing.
Catlow, C. R. A., Thomas, J. M., Freeman, C. M., Wright, P. A. & Bell, R. G. Simulating and predicting crystal structures. Proc. R. Soc. Lond. A 442, 85–96 (1993).
Bond, A. D. & Jones, W. Structure prediction as a tool for solution of the crystal structures of metallo-organic complexes using powder X-ray diffraction data. Acta Cryst. B 58, 233–243 (2002).
Gavezzotti, A. & Filippini, G. Polymorphic forms of organic crystals at room conditions: thermodynamic and structural implications. J. Am. Chem. Soc. 117, 12299–12305 (1995).
Lommerse, J. P. M. et al. A test of crystal structure prediction of small organic molecules. Acta Cryst. B 56, 697–714 (2000).
Giovannini, J., Perrin, M. A., Louer, D. & Leveiller, F. Ab initio crystal structure determination of three pharmaceutical compounds from X-ray powder diffraction data. Mater. Sci. Forum 2, 582–587 (2001).
Bond, A. D., Feeder, N., Teat, S. J. & Jones, W. The solid-state structure of 3-hydroxy-4-methyl-2(3H)-thiazolethione: prediction and measurement. Tetrahedron 56, 6617–6624 (2000).
Motherwell, W. D. S. et al. Crystal structure prediction of small molecules: a second blind test. Acta Cryst. B 58, 647–661 (2002). Describes the results from the most recent Cambridge Crystallographic Data Centre (CCDC) workshop for testing the feasibility of the various programs in predicting the crystal structure of three compounds from their individual molecular structures only.
Freeman, C. M. & Catlow, C. R. A. Structure predictions in inorganic solids. J. Chem. Soc. Chem. Comm. 2, 89–91 (1992).
Gdanitz, R. J. in Theoretical Aspects and Computer Modeling of the Molecular Solid State (ed. Gavezzotti, A.) 185–201 (Wiley, Chichester, 1997). Explains the ab initio method of crystal structure prediction.
Karfunkel, H. R. & Gdanitz, R. J. Ab initio prediction of possible crystal structures for general organic molecules. J. Comp. Chem. 13, 1171–1183 (1992).
Smith, E. D. L. et al. The determination of the crystal structure of anhydrous theophylline by X-ray powder diffraction with a systematic search algorithm, lattice energy calculations, and 13C and 15N solid-state NMR: a question of polymorphism in a given unit cell. J. Phys. Chem. B 105, 5818–5826 (2001).
Ko, G. H. & Fink, W. H. A combined quantum chemistry and classical molecular interaction energy method for the determination of crystal geometries and energies. J. Chem. Phys. 116, 747–754 (2002).
Gavezzotti, A. Organic crystals: engineering and design. Curr. Opin. Solid State Mater. Sci. 1, 501–505 (1996).
Buttar, D., Charlton, M. H., Docherty, R. & Starbuck, J. Theoretical investigations of conformational aspects of polymorphism. Part 1: o-acetamidobenzamide. J. Chem. Soc. Perkin Trans. I 2, 763–772 (1998).
Childs, S. L. Nonbonded Interactions in Molecular Crystal Structures (Emory Univ., Atlanta, 2001).
Filippini, G., Gavezzotti, A. & Novoa, J. J. Modelling the crystal structure of the 2-hydronitronylnitroxide radical (HNN): observed and computer-generated polymorphs. Acta Cryst. B 55, 543–553 (1999).
Gavezzotti, A. Methods and current trends in the simulation and prediction of organic crystal structures. Nova Acta Leopold. 79, 33–46 (1999).
Gao, D. W. & Donald, E. Molecular packing groups and ab initio crystal-structure prediction. Acta Cryst. A 55, 621–627 (1999).
Williams, D. E. I. in Crystal Engineering: From Molecules and Crystals to Materials NATO Science Series C Vol. 538 (eds Braga, D., Grepini, F. & Orpen, G. A.) 295–310 (Kluwer Academic, Boston, 1999).
Mooij, W. T. M., van Eijck, B. P. & Kroon, J. Ab initio crystal structure predictions for flexible hydrogen-bonded molecules. J. Am. Chem. Soc. 122, 3500–3505 (2000).
Allen, F. H., Kennard, O. & Taylor, R. Systematic analysis of structural data as a research technique in organic chemistry. Acc. Chem. Res. 16, 146–153 (1983).
Sarma, J. A. R. P. & Desiraju, G. R. The supramolecular synthon approach to crystal structure prediction. Cryst. Growth Des. 2, 93–100 (2002).
Mooij, W. T. M., van Eijck, B. P. & Kroon, J. Transferable ab initio intermolecular potentials. 2. Validation and application to crystal structure prediction. J. Phys. Chem. A 103, 9883–9890 (1999).
Leusen, F. J. J. Ab initio prediction of polymorphs. J. Cryst. Growth 166, 900–903 (1996).
Dong, Z. et al. Crystal structure of neotame anhydrate polymorph G. Pharm. Res. 19, 1549–1553 (2002).
Chin, D. N. Improving the efficiency of predicting hydrogen-bonded organic molecules. Trans. Am. Cryst. Assoc. 33, 33–43 (1999).
Gdanitz, R. J. Prediction of molecular crystal structures by Monte Carlo simulated annealing without reference to diffraction data. Chem. Phys. Lett. 190, 391–396 (1992). Explains the application of the Monte Carlo method in predicting crystal structures.
Hammond, R. B., Roberts, K. J., Docherty, R. & Edmondson, R. B. in Crystal Growth of Organic Materials International Workshop 4th edn (ed. Ulrich, J.) 53–60 (Shaker, Aachen, 1997).
Hammond, R. B. et al. Determining the crystal structures of organic solids using x-ray powder diffraction together with molecular and solid state modeling techniques. Molecular Crystals and Liquid Crystals Science and Technology A 356, 389–405 (2001).
Harris, K. D. M. & Tremayne, M. Crystals structure determination from powder diffraction data. Chem. Mater. 8, 2554–2570 (1996). Explains the prediction of the crystal structure of compounds from their powder diffraction data only.
Aakeroy, C. B., Beatty, A. M., Tremayne, M., Rowe, D. M. & Seaton, C. C. A combination of X-ray single crystal diffraction and Monte Carlo structure solution from X-ray powder diffraction data in a structural investigation of 5-bromonicotinic acid and solvates thereof. Cryst. Growth Des. 1, 377–382 (2001).
Will, G. POWLS: a powder least-squares program. J. Appl. Cryst. 12, 483–485 (1979).
Pawley, G. S. Unit-cell refinement from powder diffraction scans. J. Appl. Cryst. 14, 357–361 (1981).
Langford, J. I. & Louer, D. High-resolution powder diffraction studies of copper (II) oxide. J. Appl. Cryst. 24, 149–155 (1991).
Langford, J. I., Cernik, R. J. & Louer, D. The breadth and shape of instrumental line profiles in high-resolution powder diffraction. J. Appl. Cryst. 24, 912–918 (1991).
Will, G., Parrish, W. & Huang, T. C. Crystal-structure refinement by profile fitting and least-squares analysis of powder diffractometer data. J. Appl. Cryst. 16, 611–622 (1983).
Langford, J. I., Louer, D., Sonneveld, E. J. & Visser, J. W. Applications of total pattern fitting to a study of crystallite size and strain in zinc oxide powder. Powder Diffract. 1, 211–221 (1986).
David, W. I. F., Shankland, K. & Shankland, N. Routine determination of molecular crystal structures from powder diffraction data. Chem. Commun. (Camb.) 8, 931–932 (1998).
Shankland, K., David, W. I. F. & Csoka, T. Crystal structure determination from powder diffraction data by the application of a genetic algorithm. Zeit. fuer Kristall. 212, 550–552 (1997).
Harris, K. D. M., Johnston, R. L. & Kariuki, B. M. The genetic algorithm: foundations and applications in structure solution from powder diffraction data. Acta Cryst. A 54, 632–645 (1998). Explains the use of the genetic algorithm for predicting the crystal structure of compounds from their powder diffraction pattern.
Hammond, R. B., Roberts, K. J., Docherty, R. & Edmondson, M. Computationally assisted structure determination for molecular materials from X-ray powder diffraction data. J. Phys. Chem. B 101, 6532–6536 (1997).
Harris, K. D. M., Tremayne, M., Lightfoot, P. & Bruce, P. G. Crystal structure determination from powder diffraction data by Monte Carlo methods. J. Am. Chem. Soc. 116, 3543–3547 (1994).
Harris, K. D. M., Johnston, R. L., Kariuki, B. M. & Tremayne, M. A genetic algorithm for crystal structure solution from powder diffraction data. J. Chem. Res. Synop. 7, 390–391 (1998).
Harris, K. D. M. et al. Recent advances in opportunities for solving molecular crystal structures directly from powder diffraction data: new insights in crystal engineering contexts. Cryst. Eng. Comm. 4, 356–367 (2002).
Turner, G. W., Tedesco, E., Harris, K. D. M., Jonhston, R. L. & Kariuki, B. M. Implementation of Lamarckian concepts in a genetic algorithm for structure solution from powder diffraction data. Chem. Phys. Lett. 321, 183 (2000).
Habershon, S., Turner, G. W., Harris, K. D. M., Johnston, R. L. & Johnston, J. M. Gaining insights into the evolutionary behavior in genetic algorithm calculations, with applications in structure solution from powder diffraction data. Chem. Phys. Lett. 353, 185–194 (2002).
Lanning, O. J. et al. Definition of a 'guiding function' in global optimization: a hybrid approach combining energy and R-factor in structure solution from powder diffraction data. Chem. Phys. Lett. 317, 296–303 (2000).
Gilmore, C. Maximum entropy and Bayesian statistics in crystallography: a review of practical applications. Acta Cryst. A 52, 561–589 (1996). Explains the use of the maximum entropy algorithm for the prediction of the crystal structures of compounds and reviews its application.
Gilmore, C. J., Shankland, K. & Bricogne, G. Applications of the maximum entropy method to powder diffraction and electron crystallography. Proc. R. Soc. Lond. A 442, 97–111 (1993).
Presented at the fifteenth annual meeting of the National Science Teachers Association, 1966 in New York City, and reprinted from The Physics Teacher Vol. 7, issue 6, 1968, pp. 313–320 by permission of the editor and the author.
Braga, D., Desiraju, G. R., Miller, J. S., Guy Orpen, A. & Price, S. Innovation in crystal engineering. Cryst. Eng. Comm. 4, 500–509 (2002).
Pepinsky, R. Crystal engineering-new concept in crystallography. Phys. Rev. II 100, 971 (1955).
Schmidt, G. M. J. Photodimerization in solid state. Pure Appl. Chem. 647, 647–678 (1971).
Panunto, T. W., Lipkowska, Z. U., Johnson, R. & Etter, M. C. Hydrogen-bond formation in nitroanilines: the first step in designing acentric materials. J. Am. Chem. Soc. 109, 7786–7797 (1987).
Braga, D. & Fabrizia, G. in Crystal Engineering: From Molecules and Crystals to Materials (eds Braga, D., Grepioni, F. & Guy Orpen, A.) 421–441 (Kluwer Academic, Boston, 1999). Comprehensive work summarizing the recent achievements and future trends in crystal engineering.
Desiraju, G. R. Supramolecular synthons in crystal engineering — a new organic synthesis. Angew. Chem. Int. Edn Eng. 34, 2311–2327 (1995)
Walsh, B. R. D. et al. Crystal engineering of the composition of pharmaceutical phases. Chem. Commun. 2, 186–187 (2003).
Bis, J. A., Shattock, T. R. & Zaworotko, M. J. Design of binary crystals that contain pharmaceutical molecules, Abstracts of Papers, 225th ACS National Meeting, New Orleans, LA, United States, March 23–27 (2003).
McMahon, J. A. & Zaworotko, M. J. Crystal engineering of novel pharmaceutical phases, Abstracts of Papers, 225th ACS National Meeting, New Orleans, LA, United States, March 23–27 (2003).
Fleischman, S., Morales, L. A. & Zaworotko, M. J. Crystal engineering of binary crystals that contain pharmaceutical molecules, Abstracts of Papers, 223rd ACS National Meeting, Orlando, FL, United States, April 7–11 (2002).
Remenar, J. F. et al. Crystal engineering of novel cocrystals of a triazole drug with 1,4-dicarboxylic acids. J. Am. Chem. Soc. 125, 8456–8457 (2003).
Payne, R. S., Roberts, R. J. & Rowe, R. C. The mechanical properties of two forms of primidone predicted from their crystal structures. Int. J. Pharm. 145, 165–173 (1996).
Roberts, R. J., Payne, R. S. & Rowe, R. C. Mechanical property predictions for polymorphs of sulphathiazole and carbamazepine. Eur. J. Pharm. Sci. 9, 277–283 (2000).
Roberts, R. J., Rowe, R. C. & Kendall, K. Brittle–ductile transitions in die compaction of sodium chloride. Chem. Eng. Sci. 44, 1647–1651 (1989).
Roberts, R. J. & Rowe, R. C. Determination of the critical stress intensity factor (KIC) of microcrystalline cellulose using radially edge-cracked tablets. Int. J. Pharm. 52, 213–219 (1989).
Bassam, F., York, P., Rowe, R. C. & Roberts, R. J. Young's modulus of powders used as pharmaceutical excipients. Int. J. Pharm. 64, 55–60 (1990).
Roberts, R. J., Rowe, R. C. & York, P. The relationship between Young's modulus of elasticity of organic solids and their molecular structure. Powder Technol. 65, 139–146 (1991).
Nangia, A. Database research in crystal engineering. Cryst. Eng. Comm. 4, 93–101 (2002).
Gavezzotti, A. Ten years of experience in polymorph prediction: what next? Cryst. Eng. Comm. 4, 343–347 (2002).
Rohl, A. L. Computer prediction of crystal morphology. Curr. Opin. Solid State Mater. Sci. 7, 21–26 (2003).
Rajeswaran, M. et al. Three-dimensional structure determination of N-(p-tolyl)-dodecylsulfonamide from powder diffraction data and validation of structure using solid-state NMR spectroscopy. J. Am. Chem. Soc. 124, 14450–14459 (2002).
Tishmack, P. A., Bugay, D. E. & Byrn, S. R Solid-state nuclear magnetic resonance spectroscopy — pharmaceutical applications. J. Pharm. Sci. 92, 441–474 (2003).
Reutzel-Edens, S. M. & Bush, J. K. Solid-state NMR spectroscopy of small molecules: from NMR crystallography to the characterization of solid oral dosage forms. Am. Pharm. Rev. 5, 112–115 (2002).
Bugay, D. E. Characterization of the solid-state:spectroscopic techniques. Adv. Drug Del. Rev. 48, 43–65 (2001).
Taylor, L. S. & Langklide, F. W. Evaluation of solid-state forms present in tablets by Raman spectroscopy. J. Pharm. Sci., 89, 1342–1353 (2000).
Kempf, D. J. et al. ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability in humans. Proc. Natl Acad. Sci. USA 92, 2484–2488 (1995).
Chemburkar, S. R. et al. Dealing with the impact of ritonavir polymorphs on the late stages of bulk drug process development. Org. Process Res. Dev. 4, 413–417 (2000).
Young, A. The Rietveld Method International Union of Crystallography (Oxford Univ. Press, New York, 1993). Explains the Rietveld refinement method in detail.
McCusker, L. B., von Dreele, R. B., Cox, D. E., Louer, D. & Scardi, P. Rietveld refinement guidelines. J. Appl. Cryst. 32, 36–50 (1999).
Stephenson, G. A. & Young, R. Potential applications of Rietveld analysis in the pharmaceutical industry. Am. Pharm. Rev. 4, 46–51 (2001).
Kisi, E. H. Rietveld analysis of powder diffraction patterns. Mater. Forum 18, 135–153 (1994).
Rietveld, H. M. Profile refinement method for nuclear and magnetic structures. J. Appl. Cryst. 2, 65–71 (1969).
Acknowledgements
We thank A. Sheth for kindly reviewing the manuscript and for his valuable suggestions.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Related links
Glossary
- PHASE TRANFORMATION
-
The transformation of a solid from one physical form to another. Phase transformation can involve the transformation of a single component into one or more components, and can result from changes in physical conditions, as in pharmaceutical processing. Examples of phase transformation include polymorphic transitions, crystallization of amorphous solids, and solid-state solvation and desolvation.
- MOLECULAR ADDUCT
-
A crystal is termed a molecular adduct when its lattice consists of more than one chemical component.
- SOLVATE
-
A solid phase that contains solvent molecules, in addition to molecules of the major component, in the crystal lattice.
- HYDRATE
-
A solid phase that contains water molecules, in addition to molecules of the major component, in the crystal lattice.
- HYDROGEN BOND
-
An attractive interaction between two electronegative atoms through a hydrogen bridge. The hydrogen bond is partly electrostatic and partly covalent in nature, with limited orbital overlap between the participating atoms. Of the two electronegative atoms, one is the proton donor and the other is a proton acceptor. When present within the same molecule, a hydrogen bond is termed intramolecular. When present between two molecules, a hydrogen bond is termed intermolecular.
- SLIP SYSTEM
-
The term slip refers to the translational motion of lattice planes relative to each other. Such planes are termed slip planes. A family of slip planes, together with the slip direction, is termed a slip system.
- ENANTIOTROPE
-
The members of a pair of polymorphs are termed enantiotropes when their mutual transition temperature is less than the melting point of either polymorph. Each enantiotrope has its own temperature range of stability.
- MONOTROPE
-
The members of a pair of polymorphs are termed monotropes when they have no mutual transition temperature. One monotrope is always more stable than the other polymorph under all conditions in which the solid state can exist.
- ISOLATED SITE HYDRATE
-
In an isolated site hydrate, the water molecules in the crystal lattice of the hydrate are isolated from direct contact with other water molecules by intervening molecules of the major component.
- ION-ASSOCIATED HYDRATE
-
In an ion-associated hydrate, the water molecules in the crystal lattice of the hydrate are coordinated to certain ions (often metal ions).
- CHANNEL HYDRATE
-
In a channel hydrate, the water molecules present in the crystal lattice of the hydrate lie next to other water molecules of adjoining unit cells, forming channels through the crystals along a direction in the lattice.
- EXPANDED CHANNEL HYDRATE
-
An expanded channel hydrate can take up water into the channels when exposed to relatively high humidity and can release water from the channels when exposed to relatively low humidity. The crystal lattice can expand or contract as hydration or dehydration proceeds, changing the dimensions of the unit cell.
- PLANAR HYDRATE
-
A planar hydrate is a channel hydrate in which water molecules are localized in a plane, corresponding to two-dimensional order.
- SOLID SOLUTION
-
A solid solution can be substitutional or interstitial. A substitutional solid solution is a homogeneous crystalline phase in which some of the constituent molecules are substituted by foreign molecules that possess sufficient similarity that the lattice dimensions are changed only slightly. In an interstitial solid solution, the foreign molecules are inserted into interstitial positions, such that the lattice dimensions are changed only slightly.
- IMPROPER ROTATION ELEMENT
-
A 360°/n rotation about an n-fold axis of improper rotation, followed by a reflection through a mirror plane perpendicular to the rotation axis.
- SYNCHROTRON
-
An electron accelerator that uses synchronized magnetic fields. When the high-speed electrons are directed to collide with an appropriate target, high-energy X-ray radiation or ultraviolet radiation is produced.
- MELT
-
When a solid is heated beyond its melting temperature, it fuses (melts) to produce a liquid that can be termed a melt.
- EPITAXIAL GROWTH
-
The growth of one crystal on the surface of another crystal (the substrate), on which the growth of the deposited crystal is oriented by the lattice structure of the substrate.
- CAPILLARY CRYSTALLIZATION
-
A specific crystallization technique in which the crystals nucleate and grow inside a capillary as a result of slow solvent evaporation.
- SYSTEMATIC ABSENCES
-
The systematic absence of specific groups of reflections in a diffraction pattern of a crystal indicates the presence of certain symmetry elements and enables the crystallographic space group of the crystal lattice to be defined.
- PATTERSON METHOD
-
The Patterson method employs the relatively large electron diffraction resulting from the presence of heavy atoms (atomic number >17) to determine the crystal structures of inorganic and organic compounds.
- ISOMORPHOUS REPLACEMENT METHOD
-
In the isomorphous replacement method, a heavy atom is introduced into the crystal lattice without disrupting the original crystal structure. The new crystal obtained is known as the derivative crystal. The aim of isomorphous replacement is to obtain the structure of the original crystal by constructing a map (that is, a Patterson map) of the difference in electron density between the diffraction pattern of the derivative crystal and that of the heavy atom. This method is used to determine the crystal structures of proteins.
- TAUTOMERISM
-
An equilibrium, usually under ambient conditions, of two isomers of a compound.
- SPORANOX BEAD
-
An amorphous capsule that is used to achieve the required oral bioavailability of extremely water-insoluble drugs, such as itraconazole.
- YOUNG'S MODULUS
-
A measure of a material's elasticity, which is defined as the force per unit cross-section of the material divided by the fractional increase in length that results from the stretching of a standard specimen of the material.
Rights and permissions
About this article
Cite this article
Datta, S., Grant, D. Crystal structures of drugs: advances in determination, prediction and engineering. Nat Rev Drug Discov 3, 42–57 (2004). https://doi.org/10.1038/nrd1280
Issue Date:
DOI: https://doi.org/10.1038/nrd1280
- Springer Nature Limited
This article is cited by
-
The synthesis, thermal behaviour, spectral and structural characterization, and in silico prediction of pharmacokinetic parameters of tetraalkylammonium salts of non-steroidal anti-inflammatory drug nimesulide
Scientific Reports (2023)
-
Adsorption and release of diphenhydraminium ibuprofenate from SBA-15 and MCM-41 explained by intermolecular interactions
Journal of Materials Science (2023)
-
Effect of fine-tuning of intermolecular interactions on crystallisation outcome: A case study of polymorphs of 4-hydroxybenzaldehyde
Pramana (2022)
-
Mechanisms of Crystal Plasticization by Lattice Water
Pharmaceutical Research (2022)
-
X-ray fan beam coded aperture transmission and diffraction imaging for fast material analysis
Scientific Reports (2021)